RPL22L1 and colorectal carcinoma: In addition, comparing the MAP signature and MSI signature from the recently developed preMSIm, five genes (MLH1, RPL22L1, EPM2AIP1, DDX27, and SHROOM4) were observed in both signatures in CRC (Fig. 3c).